Sinopharm Holdings (01099): Sinopharm's net profit for the medium term was 606 million yuan, a year-on-year decrease of 8.97%

Zhitongcaijing · 2d ago

According to the Zhitong Finance App, Sinopharm Holdings (01099) announced Sinopharm's consistent results for the six months ended June 30, 2026, with total operating income of 36.266 billion yuan, a decrease of 1.44% year on year; net profit attributable to shareholders of listed companies was 606 million yuan, a decrease of 8.97% year on year; basic earnings per share were 0.99 yuan.